ライフサイエンスコーパス: communicable disease

1 ies (around 80% of DALYs attributable to non-communicable disease).

2 Tuberculosis is a major communicable disease.

3 Obesity is a common cause of non-communicable disease.

4 is little evidence that they are vectors of communicable disease.

5 here three-quarters of mortality is from non-communicable disease.

6 hich has a growing prevalence of chronic non-communicable disease.

7 n metabolic syndrome, diabetes and other non-communicable diseases.

8 with no discernible funding targeted to non-communicable diseases.

9 the effective prevention and containment of communicable diseases.

10 rt of a comprehensive strategy to reduce non-communicable diseases.

11 ammation rooted in both communicable and non-communicable diseases.

12 ould be a risk of development of chronic non communicable diseases.

13 e no detailed assessments of late-onset, non-communicable diseases.

14 ological transition from communicable to non-communicable diseases.

15 annually through its effects on multiple non-communicable diseases.

16 patterns are a global priority to reduce non-communicable diseases.

17 beginning to confront the rising tide of non-communicable diseases.

18 rtality, growth failure, and adult-onset non-communicable diseases.

19 in the context of the growing burden of non-communicable diseases.

20 s with expertise in control of infection and communicable diseases.

21 d help prevent such diet-related chronic non-communicable diseases.

22 sk factors that include communicable and non-communicable diseases.

23 val and reduce disability, stunting, and non-communicable diseases.

24 tributor to adult obesity, diabetes, and non-communicable diseases.

25 and to address the emerging burden from non-communicable diseases.

26 neonatal, and nutritional causes towards non-communicable diseases.

27 major modifiable risk factor for chronic non-communicable diseases.

28 ealth services, but poorly in addressing non-communicable diseases.

29 eg, US$1029.10 for HIV/AIDS to $3.21 for non-communicable diseases.

30 icant heterogeneities in the transmission of communicable diseases.

31 partly because of the overwhelming burden of communicable diseases.

32 ated into management of communicable and non-communicable diseases.

33 ere diabetes must compete for resources with communicable diseases.

34 added visceral fat and increased risk of non-communicable diseases.

35 and to establish syndromic surveillance for communicable diseases.

36 ture rate of decline in communicable and non-communicable diseases.

37 ove treatment effectiveness, and address non-communicable diseases.

38 fing PPE for simulated patients with serious communicable diseases.

39 ive development, and increase risks from non-communicable diseases.

40 ng populations and the growing burden of non-communicable diseases.

41 it potential biological activity against non-communicable diseases.

42 h preventing and controlling the rise of non-communicable diseases.

43 k of hormone-sensitive cancers and other non-communicable diseases.

44 revalent dual burden of communicable and non-communicable diseases.

45 as obesity, diabetes, and other chronic non-communicable diseases.

46 e richest 20% from a similar increase in non-communicable diseases (1.4 vs 5.3 years).

47 n Plan for the Prevention and Control of Non-communicable Diseases 2013-2020, and in advancing the UN

48 on precautions for patients with potentially communicable diseases; 4) proper use of personal protect

49 c health information in general (49 states), communicable diseases (42 states), and sexually transmit

50 (-9.64%, 95% CI -6.38 to -12.90), other non-communicable diseases (-9.14%, -4.26 to -14.02), and tub

51 millions of adults at increased risk of non-communicable diseases after low birthweight.

52 minants are relevant to communicable and non-communicable disease alike.

53 Transborder spread of communicable diseases also challenges communicable disea

54 tions age, and as progress continues against communicable diseases among infants and children.

55 veloping an understanding of the dynamics of communicable disease and assisting the construction and

56 C, especially as countries pivot towards non-communicable disease and injury care.

57 reduce mortality at age 5-69 years from non-communicable disease and injury comprising the highest s

58 The communicable disease and non-communicable disease sector

59 the UN's political commitment to address non-communicable diseases and ensure universal access to dru

60 inued to shift away from communicable to non-communicable diseases and from premature death to years

61 nized as a major risk factor for chronic non-communicable diseases and has been estimated to contribu

62 l persist in LICs--whereas the burden of non-communicable diseases and injuries has increased.

63 n learnt about prevention and control of non-communicable diseases and injuries, which is well summar

64 ow confronting an increasing burden from non-communicable diseases and injuries.

65 almost half of expected disability is due to communicable diseases and injuries.

66 ion with age-standardised mortality from non-communicable diseases and injuries.

67 ceed the incremental gains in decreasing non-communicable diseases and injury burdens of high-income

68 ommunicable diseases narrowed over time, non-communicable diseases and injury burdens varied markedly

69 nds in deaths caused by communicable and non-communicable diseases and injury.

70 nificant global health burdens from both non-communicable diseases and micronutrient deficiencies.

71 rly 90% of expected disability is due to non-communicable diseases and most of the remainder to injur

72 ns, while at the same time, diet-related non-communicable diseases and obesity have exponentially inc

73 Urgent action is now required to control non-communicable diseases and reduce fatal injuries in Mexic

74 onal differences in the unfinished agenda of communicable diseases and reproductive, maternal, and ch

75 e solution is city planning that reduces non-communicable diseases and road trauma while also managin

76 of infections allows treatment of potential communicable diseases and updating of immunizations.

77 is study shows the reversal of HIV/AIDS, non-communicable disease, and injury mortality trends in Sou

78 side from HIV/AIDS, few CL episodes involved communicable disease, and none occurred in least-develop

79 tal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries.

80 alth security, antimicrobial resistance, non-communicable diseases, and climate change-but also the t

81 rders increase risk for communicable and non-communicable diseases, and contribute to unintentional a

82 (MDGs), addressing growing challenges of non-communicable diseases, and ensuring universal health cov

83 Mortality from tuberculosis, non-communicable diseases, and injuries decreased slightly.

84 rnal, perinatal, and nutritional causes, non-communicable diseases, and injury.

85 al budget to infectious diseases, 12% to non-communicable diseases, and less than 1% to injuries and

86 ogenic agents is likely to prevent other non-communicable diseases, and the cause could be removed or

87 ale natural disasters, epidemics of multiple communicable diseases, and the shift towards non-communi

88 ns when caring for patients with potentially communicable diseases; and 5) evaluation of personnel wi

89 atal, and nutritional disorders; second, non-communicable diseases; and third, injuries.

90 dult mortality risks from infections and non-communicable diseases are a result of historical childho

91 Non-communicable diseases are increasingly common causes of

92 poor, which population interventions for non-communicable diseases are most applicable in different c

93 Chronic, non-communicable diseases are now recognised as diseases tha

94 Non-communicable diseases are the leading global cause of de

95 Non-communicable diseases are, however, already major public

96 Since this transition, the prevention of non-communicable disease as well as communicable disease cau

97 earance or severity of multiple chronic, non-communicable diseases, as these diseases share the same

98 ciation between socioeconomic status and non-communicable disease behavioural risk factors is well es

99 cated in substantial global increases in non-communicable disease burden in low-income, remote, and I

100 otal disease burden in 2016, whereas the non-communicable disease burden increased.

101 an ageing global population comes major non-communicable disease burden, especially in low-income an

102 Given the changing nature of communicable disease burden, subnational vaccination may

103 ment (PPE) can limit transmission of serious communicable diseases, but this process poses challenges

104 rd reduction in premature mortality from non-communicable diseases by 2030.

105 itiative, a plan to cut mortality due to non-communicable diseases by 25% by 2025.

106 tobacco use and premature mortality from non-communicable diseases by a third by 2030.

107 re developed for key nutrients linked to non communicable diseases by an independent scientific commi

108 ct of physical inactivity on these major non-communicable diseases by estimating how much disease cou

109 l to reduce rates of death from chronic (non-communicable) disease by an additional 2% every year.

110 y later overweight increases the risk of non-communicable disease, by imposing a high metabolic load

111 vative assumptions for each of the major non-communicable diseases, by country, to estimate how much

112 ch about half the mortality reduction in non-communicable diseases called for by the Sustainable Deve

113 D-19 pandemic has shown how a newly emergent communicable disease can lay considerable burden on publ

114 ing factual information about the dangers of communicable diseases can positively impact people's att

115 fting burden from infectious diseases to non-communicable diseases, cancer care for all ages has beco

116 Among chronic non-communicable diseases, cardiometabolic diseases and canc

117 den of Disease Study 2010, the burden of non-communicable diseases (cardiovascular disease, cancer, c

118 Diphtheria is an acute, communicable disease caused by Corynebacterium diphtheri

119 In 1990, communicable diseases caused 59% of death and disability

120 world's richest 20%, on the other hand, non-communicable diseases caused 85% of death and disability

121 onitoring of patients with other symptomatic communicable diseases caused by E. coli at global scale.

122 ntion of non-communicable disease as well as communicable disease causes of adolescent mortality has

123 became the first chief epidemiologist at the Communicable Disease Center (CDC) in Atlanta, Georgia.

124 When the Communicable Disease Center (now the Centers for Disease

125 He was hired by the US Communicable Disease Center (now the Centers for Disease

126 I outline the Communicable Disease Center's first surveillance systems

127 The Communicable Disease Center, now the Centers for Disease

128 alth Service, which at the time included the Communicable Disease Center, the Centers for Disease Con

129 Hypertension is a non-communicable disease characterized by elevated blood pre

130 rganization was notified of an outbreak of a communicable disease characterized by fever, severe diar

131 However, amid Mexico's progress against communicable diseases, chronic kidney disease burden rap

132 Data were collected for communicable diseases commonly screened for during the e

133 e notification database at the Department of Communicable Disease Control and Prevention in Stockholm

134 ead of communicable diseases also challenges communicable disease control systems within the EU.

135 stems are to meet the emerging challenges to communicable disease control.

136 entation of an effective response to the non-communicable-disease crisis will need political commitme

137 A raised baseline rate of communicable disease decline between 1990 and 2020 would

138 The burden of communicable diseases decreased but continues to predomi

139 injuries, cancers, cirrhosis, and other non-communicable diseases, democratic experience explains mo

140 National Institute for Communicable Diseases: Division of the National Health L

141 of overweight, obesity, and diet-related non-communicable diseases (DR-NCDs) have been proposed as a

142 individuals towards risk of Diet Related Non-communicable Diseases (DR-NCDs).

143 al Administrative Region, Harvard Center for Communicable Disease Dynamics from the National Institut

144 ramme and Wellcome Trust, Harvard Center for Communicable Disease Dynamics, and Health and Medical Re

145 The changing patterns of communicable diseases east of the EU's new border has im

146 child health, other infectious diseases, non-communicable diseases, Ebola, and sector-wide approaches

147 Development Goals and the challenges of non-communicable diseases, economic inequality, and climate

148 modify the major risk factors related to non-communicable diseases, especially physical inactivity an

149 DALYs from non-communicable diseases--especially ischaemic heart diseas

150 isorders including diabetes, cardiovascular, communicable diseases etc.

151 uintile for HIV/AIDS and tuberculosis, other communicable diseases (excluding HIV/AIDS and tuberculos

152 rominently in the burgeoning epidemic of non-communicable diseases facing low- and middle-income coun

153 rders accounted for 17.2 million deaths, non-communicable diseases for 28.1 million deaths and injuri

154 illness (ILI) to the National Institute for Communicable Diseases for influenza testing by immunoflu

155 5) evaluation of personnel with exposure to communicable diseases for receipt of postexposure prophy

156 e burden of morbidity and mortality from non-communicable disease has risen worldwide and is accelera

157 logical evidence, the policy response to non-communicable diseases has been weak.

158 High rates of non-communicable diseases have also been described with evid

159 wever, socioeconomic factors influencing non-communicable diseases have not been included in the plan

160 and nutritional diseases; injuries; and non-communicable diseases); health risks (tobacco smoking, b

161 iven to the issue of access to medicines for communicable diseases; however, access to essential medi

162 lth service use of an additional chronic non-communicable disease in different socioeconomic groups a

163 ned from a community-based management of non-communicable disease in Nepal (COBIN) Wave II study, whi

164 ctors that have contributed to the growth of communicable disease in Russia, Ukraine, and Belarus; se

165 ted to the Norwegian Surveillance System for Communicable Diseases in 2005-2014 and 249998 individual

166 edictive values (PPVs) of ICD-9-CM codes for communicable diseases in 6 North Carolina health-care sy

167 e diseases in children towards those for non-communicable diseases in adults.

168 society by preventing and treating not only communicable diseases in all ages, but also noncommunica

169 Asthma-one of the most common chronic, non-communicable diseases in children and adults-is characte

170 stantially, with a shift away from risks for communicable diseases in children towards those for non-

171 han 3 million deaths per year, most from non-communicable diseases in low-income and middle-income co

172 Global and regional estimates show that non-communicable diseases in old age are rising in importanc

173 health guidance on prevention and control of communicable diseases in prison settings.

174 unicable diseases, and the shift towards non-communicable diseases in recent decades.

175 , care, and treatment, and management of non-communicable diseases in the poorest populations.

176 2008, with 446 annual excess deaths from non-communicable diseases in the UK (280 for young people ag

177 Mortality from non-communicable diseases in the UK fell from being roughly

178 has been among the most frequently reported communicable diseases in the United States since 1960.

179 ne of the most common, life-threatening, non-communicable diseases in the world and a major public he

180 ight the need to focus more attention on non-communicable diseases in this population and balance obe

181 nges of contact tracing for high-consequence communicable diseases included rapid comprehensive conta

182 s early life factors in the aetiology of non-communicable diseases, including asthma/wheezing disorde

183 Non-communicable diseases, including cancer, are overtaking

184 regions, and has an increasing burden of non-communicable diseases, including cardiovascular diseases

185 flict includes death and disability from non-communicable diseases, including diabetes, which have la

186 l epidemiological trends and the rise of non-communicable diseases, including diabetes.

187 The most common non-communicable diseases, including ischaemic heart disease

188 rly for infant deaths and mortality from non-communicable diseases, including neuropsychiatric disord

189 t bacteria, mass casualty incidents, and non-communicable diseases, including thermal disorders.

190 reflected in changes in the epidemiology of communicable diseases, including tuberculosis and HIV (i

191 ICs, with interventions focused primarily on communicable diseases, including tuberculosis and malari

192 everal risks that primarily affect childhood communicable diseases, including unimproved water and sa

193 hy eating guidelines that aim to prevent non-communicable diseases (increase fruits, vegetables, whol

194 Deaths from non-communicable diseases increased over time in both sexes,

195 As the prevalence of injuries and non-communicable diseases increases, the provision of effect

196 ommendations: WHO's package of essential non-communicable disease interventions (PEN) and South Afric

197 and diagnostic yield of integrating NCD and communicable diseases into a rapid HIV testing and refer

198 ty of integrating hypertension, diabetes and communicable diseases into HIV initiatives.

199 obability of a man or woman dying from a non-communicable disease is higher in sub-Saharan Africa and

200 ntries in the Gulf region, the burden of non-communicable diseases is a major threat, primarily due t

201 The epidemiological transition towards non-communicable diseases is characterised by an upward shif

202 and increasing burden of mortality from non-communicable diseases is likely to become prominent.

203 f two or more mental or physical chronic non-communicable diseases, is a major challenge for the heal

204 lions of patients suffering from chronic non-communicable disease like diabetes.

205 by mass drug administration programs against communicable diseases may necessitate increased vector c

206 tis programme that offers a portfolio of non-communicable disease medicines at a wholesale price of U

207 ated at the international level, such as non-communicable diseases, mental health, and injuries.

208 ustainable Development Goals 3.4 (reduce non-communicable disease morbidity by a third by 2030) and 3

209 opment Goal (SDG) 3.4-reducing premature non-communicable disease mortality by a third by 2030-should

210 We projected that non-communicable disease mortality will increase from 28.1 m

211 e varied substantially by health topic, from communicable diseases (n=131), nutrition (n=77), to non-

212 e diseases (n=131), nutrition (n=77), to non-communicable diseases (n=8), and water, sanitation, and

213 Although state inequalities from communicable diseases narrowed over time, non-communicab

214 Most countries have endorsed WHO non-communicable disease (NCD) best buy policies, but we kno

215 The non-communicable disease (NCD) burden in Kenya is not well c

216 disease contributes substantially to the non-communicable disease (NCD) burden in low-income and midd

217 age and gender, by communicable (CD) and non-communicable disease (NCD) causes.

218 ession was used to analyse all-cause and non-communicable disease (NCD) mortality between 2006 and 20

219 The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambi

220 et 3.4, current policy and monitoring of non-communicable disease (NCD) mortality trends focus on peo

221 Heightened risk of non-communicable diseases (NCD) in children exposed to SAM a

222 income countries, care for patients with non-communicable diseases (NCDs) and mental health condition

223 Non-communicable diseases (NCDs) are leading causes of prema

224 e premature mortality from the four main non-communicable diseases (NCDs) by 25% from 2010 levels by

225 Non-communicable diseases (NCDs) cause a large burden of dis

226 approaches to prevention and control of non-communicable diseases (NCDs) have been elaborated in the

227 The burden of non-communicable diseases (NCDs) is disproportionately carri

228 World Health Organization 2014 report on non-communicable diseases (NCDs) only listed smoking, alcoho

229 Non-communicable diseases (NCDs) such as cardiovascular dise

230 unities have a higher risk of dying from non-communicable diseases (NCDs) than do more advantaged gro

231 tes to the development of many prevalent non-communicable diseases (NCDs), and these lifestyle-associ

232 ps remain in quality of care, control of non-communicable diseases (NCDs), efficiency in delivery, co

233 xperiencing an increase in the burden of non-communicable diseases (NCDs), including cancer.

234 As with most non-communicable diseases (NCDs), oral conditions are chroni

235 of 30 years and 70 years) from four main non-communicable diseases (NCDs)--cardiovascular diseases, c

236 le will increasingly develop age-related non-communicable diseases (NCDs).

237 vide an untapped opportunity to identify non-communicable diseases (NCDs).

238 tion leading to increasing prevalence of non-communicable diseases (NCDs).

239 isk factors shared with a range of other non-communicable diseases (NCDs).

240 deaths; a third of premature deaths from non-communicable diseases (NCDs); and a third of those from

241 The threat of non-communicable diseases ("NCDs") is increasingly becoming

242 action: malaria 8.0% and syphilis 7.7%), non-communicable diseases, nutrition and lifestyle factors (

243 Sequencing pathogen samples during a communicable disease outbreak is becoming an increasingl

244 he HIV epidemic, and increasing rates of non-communicable diseases, people in sub-Saharan Africa are

245 Cancer is one of the major non-communicable diseases posing a threat to world health.

246 Despite mortality due to communicable diseases, poverty, and human conflicts, dem

247 rategy of seeking natural factors in the non-communicable diseases prevention, but their sensory qual

248 Growing political recognition of non-communicable diseases provides a favourable political co

249 The rise in diabetes and other non-communicable diseases puts a heavy toll on health system

250 mong 10,040 Kurdish adults from Ravansar Non-Communicable Disease (RaNCD) cohort study in Iran.

251 o other strategies to address increasing non-communicable disease rates must be pursued.

252 rs, due to population ageing, changes in non-communicable disease rates, and increasing air pollution

253 s and regions, although communicable and non-communicable diseases remained the main causes of death

254 Controlling an emerging communicable disease requires prompt adoption of measure

255 of diets associated with lower or higher non-communicable disease risk on the basis of multivariate m

256 Deaths from non-communicable diseases rose by just under 8 million betwe

257 focus areas (other infectious diseases, non-communicable diseases, sector-wide approaches, and other

258 The communicable disease and non-communicable disease sectors need to move beyond convent

259 In the 1960s and 1970s, communicable disease seemed a minor threat, but since th

260 cal guidelines for GAS pharyngitis and other communicable diseases should be considered for reducing

261 t in the global monitoring framework for non-communicable diseases should promote accountability for

262 ciated with the damaging inflammation of non-communicable disease states and is considered an attract

263 Treatment of non-communicable diseases such as cancer in refugees is negl

264 verse health conditions, including major non-communicable diseases such as coronary heart disease, ty

265 f many pathologies, particularly chronic non-communicable diseases such as obesity and diabetes.

266 s, one can find regions having predominantly communicable diseases such as rheumatic heart disease, t

267 ses has provoked a renewed focus on European communicable disease surveillance and control.

268 dated hospital discharge data unsuitable for communicable disease surveillance.

269 and prescribed medicines for one of the non-communicable diseases targeted by the programme: hyperte

270 Worldwide, communicable and non-communicable diseases tend to segregate geographically.

271 We assess risks of communicable diseases that are associated with mass gath

272 coronary heart disease and other chronic non-communicable diseases that lower global life expectancie

273 nfancy and childhood as well as chronic, non-communicable diseases that may manifest at any point acr

274 Unlike most communicable diseases, the absolute burden and relative

275 transitions from diseases of poverty to non-communicable diseases, the burden of disease and health

276 n accelerated rate of overall decline in non-communicable diseases, the poor-rich gap would widen.

277 a reduction in global child mortality due to communicable diseases, the relative contribution of cong

278 stablished U.S. guidelines for visitors with communicable diseases, thereby not limiting the rights o

279 e to worldwide epidemics of injuries and non-communicable diseases through traffic exposure, noise, a

280 te the risk of cardiometabolic and other non-communicable diseases through various mechanisms.

281 We used 11 physical non-communicable diseases to measure physical multimorbidity

282 DC from an agency focused almost entirely on communicable diseases to one engaged in a broad array of

283 The burden of non-communicable diseases, to which cancer contributes great

284 Among communicable diseases, tuberculosis is the second leadin

285 nd a third of those from other causes (other communicable diseases, undernutrition, and injuries).

286 Moreover, high costs for non-communicable diseases warrant new features for preventio

287 An additional chronic non-communicable disease was associated with an increase in

288 f patient charts with ICD-9-CM diagnoses for communicable diseases were reviewed and evaluated for th

289 Substantial declines in death caused by communicable diseases were seen in all age-groups and re

290 n treatment, blood glucose level, having non-communicable diseases were significantly associated with

291 Most increases in DALYs, especially from non-communicable diseases, were due to population growth.

292 ies (around 50% of DALYs attributable to non-communicable disease), whereas China more closely resemb

293 r Ingelheim; Department of Management of Non-Communicable Diseases, WHO; and Population Health Resear

294 ed by a novel coronavirus (CoV), is a highly communicable disease with the lungs as the major patholo

295 culosis remains one of the world's deadliest communicable diseases with 10 million incident cases and

296 herapies include commonly used drugs for non-communicable diseases with good safety profiles, immunom

297 ity on addressing the high prevalence of non-communicable diseases, with variations in policies betwe

298 al artery disease is a prevalent chronic non-communicable disease without obvious symptoms.

299 s and accounts for the largest burden of non-communicable diseases worldwide.

300 As a result, a faster decline in communicable diseases would decease the poor-rich gap in